Application number: |
P200200607 |
Patent number: |
|
PCT application number: |
EP01/04783 |
Filing date of the application: |
27.04.2001 |
Publication date: |
15.04.2004 |
Date of the grant of the patent: |
|
Priority date: |
28.04.2000 20.01.2001
|
Estonian title : |
2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena |
English title : |
2-acyl indol derivatives and their use as anti-tumour agents |
Status: |
Application withdrawn, deemed to be withdrawn or rejected |
Fees paid for the years of validity : |
6 |
IPC class: |
C07D209/12 C07D403/06 C07D209/14 C07D487/04 C07D403/04 A61K31/40 A61K31/44 A61K31/47 A61K31/435 A61P35/00
|
CPC class: |
|
Estonian abstract: |
Leiutis käsitleb uusi üldvalemiga (I) indool- ja heteroindoolderivaate, nende tautomeere, stereoisomeere, nende segusid ja sooli, nende valmistamist ning üldvalemiga (I) indoolderivaatide kasutamist ravimitena.
|
English abstract: |
The invention relates to novel indol and heteroindol derivatives of the general formula (I), to their tautomers, stereoisomers, their mixtures and their salts, to the production thereof and to the use of indol derivatives of the general formula (I) as medicaments.
|
Applicant/holder: |
Baxter Healthcare SA
|
Inventor name: |
Thomas Beckers (DE) Silke Baasner (DE) Thomas Klenner (DE) Siavosh Mahboobi (DE) Herwig Pongratz (DE) Markus Frieser (DE) Harald Hufsky (DE) Jörg Hockemeyer (DE) Heinz-Herbert Fiebig (DE) Angelika Burger (DE) Frank-D Böhmer (DE)
|
Drawing(s): Click on the drawing to display a larger drawing!
|
|
Published patent application:
|
Display the published patent application (Document A) |
Patent attorney: |
Jaak Ostrat |
|
|
Display: |
DATA OF THE FEES |